Insight 2811’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
Insight 2811's NAGE Position: Q3 2026 in Review
Insight 2811 held its Niagen Bioscience (NAGE) position steady in Q3 2026 at 22,834 shares worth $66.7K. The position accounts for 0.03% of the portfolio, ranked #110.
Insight 2811 first reported a position in NAGE in Q4 2019 and has held it in 7 quarters since. The position peaked at $158K in Q2 2020. 92 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- Insight 2811 held 22,834 shares of Niagen Bioscience worth $66.7K as of Q3 2026.
- Insight 2811 left its Niagen Bioscience share count unchanged in Q3 2026.
- Niagen Bioscience made up 0.03% of Insight 2811's portfolio in Q3 2026, its #110 holding.
- Insight 2811 first reported a position in Niagen Bioscience in Q4 2019 and has held it in 7 quarters since.
- Insight 2811's Niagen Bioscience position peaked at $158K in Q2 2020.
- 92 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on Insight 2811's 13F filing for Q3 2026, filed 6 Nov 2026.